找到约 23 条 “RO495” 相关结果 (用时 0.296 秒)
目录号 | 产品名称 | 中文名称 | 靶点 |
---|---|---|---|
M12015 | ChemBridge-5349520 | ChemBridge化合物-5349520 | Screening Compounds and Building Blocks |
N-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide (5349520) | |||
ChemBridge特有类药化合物/先导化合物-5349520,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12375 | ChemBridge-5806495 | ChemBridge化合物-5806495 | Screening Compounds and Building Blocks |
2-[2-(4-hydroxyphenyl)vinyl]-4(3H)-quinazolinone (5806495) | |||
ChemBridge特有类药化合物/先导化合物-5806495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M12462 | ChemBridge-5947495 | ChemBridge化合物-5947495 | Screening Compounds and Building Blocks |
N-(5-chloro-2-methoxyphenyl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (5947495) | |||
ChemBridge特有类药化合物/先导化合物-5947495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M13117 | ChemBridge-7967495 | ChemBridge化合物-7967495 | Screening Compounds and Building Blocks |
7-{(3-pyridinylamino)[4-(trifluoromethyl)phenyl]methyl}-8-quinolinol (7967495) | |||
ChemBridge特有类药化合物/先导化合物-7967495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M13248 | ChemBridge-16495278 | ChemBridge化合物-16495278 | Screening Compounds and Building Blocks |
N-{[3-(6-methoxy-2-naphthyl)-1H-pyrazol-4-yl]methyl}-2-methyl-1-(5-methyl-1H-benzimidazol-2-yl)-1-propanamine (16495278) | |||
ChemBridge特有类药化合物/先导化合物-16495278,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M13287 | ChemBridge-49593017 | ChemBridge化合物-49593017 | Screening Compounds and Building Blocks |
4-[(1-ethyl-3-methyl-1H-pyrazol-5-yl)carbonyl]-7-[(4-phenyl-1-piperazinyl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine (49593017) | |||
ChemBridge特有类药化合物/先导化合物-49593017,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M20744 | RO495 | RO495 | JAK |
CS-2667 | |||
RO495 (CS-2667) is a potent inhibitor of Non-receptor tyrosine-protein kinase 2 (TYK2). | |||
M45519 | ChemBridge-5244955 | ChemBridge化合物-5244955 | Screening Compounds and Building Blocks |
methyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate (5244955) | |||
ChemBridge特有类药化合物/先导化合物-5244955,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M46981 | ChemBridge-9149542 | ChemBridge化合物-9149542 | Screening Compounds and Building Blocks |
5-hydroxy-3-(1-methyl-1H-benzimidazol-2-yl)pyrrolo[1,2-a]quinazolin-2(1H)-one (9149542) | |||
ChemBridge特有类药化合物/先导化合物-9149542,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47257 | ChemBridge-10495716 | ChemBridge化合物-10495716 | Screening Compounds and Building Blocks |
5-[(3-fluorophenoxy)methyl]-N-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrazole-3-carboxamide (10495716) | |||
ChemBridge特有类药化合物/先导化合物-10495716,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47320 | ChemBridge-12495998 | ChemBridge化合物-12495998 | Screening Compounds and Building Blocks |
N-acetyl-N-[2-(4-oxo-3,4-dihydroquinazolin-2-yl)ethyl]-L-histidinamide (12495998) | |||
ChemBridge特有类药化合物/先导化合物-12495998,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47336 | ChemBridge-13049552 | ChemBridge化合物-13049552 | Screening Compounds and Building Blocks |
2-[(5-methyl-2-thienyl)methyl]-3a-(2-phenylethyl)-5-(2-pyrazinyl)octahydropyrrolo[3,4-c]pyrrole (13049552) | |||
ChemBridge特有类药化合物/先导化合物-13049552,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47559 | ChemBridge-21495589 | ChemBridge化合物-21495589 | Screening Compounds and Building Blocks |
2'-methoxy-N-[3-(3-oxopiperazin-1-yl)propyl]biphenyl-3-carboxamide (21495589) | |||
ChemBridge特有类药化合物/先导化合物-21495589,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M47613 | ChemBridge-23495196 | ChemBridge化合物-23495196 | Screening Compounds and Building Blocks |
1-{rel-(3R,4S)-4-hydroxy-1-[4-methoxy-3-(1H-1,2,4-triazol-1-ylmethyl)benzyl]-3-pyrrolidinyl}-N,N-dimethylmethanesulfonamide (23495196) | |||
ChemBridge特有类药化合物/先导化合物-23495196,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48003 | ChemBridge-39012495 | ChemBridge化合物-39012495 | Screening Compounds and Building Blocks |
3-(2-methoxy-5-methylphenyl)-5-(trifluoromethyl)-1H-1,2,4-triazole (39012495) | |||
ChemBridge特有类药化合物/先导化合物-39012495,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48018 | ChemBridge-39949553 | ChemBridge化合物-39949553 | Screening Compounds and Building Blocks |
N-benzyl-8-methoxy-3-chromanamine (39949553) | |||
ChemBridge特有类药化合物/先导化合物-39949553,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48130 | ChemBridge-44952195 | ChemBridge化合物-44952195 | Screening Compounds and Building Blocks |
1-(3-chloro-1H-indol-2-yl)-N-[(1,3-dimethylpyrrolidin-3-yl)methyl]-N-methylmethanamine (44952195) | |||
ChemBridge特有类药化合物/先导化合物-44952195,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M48254 | ChemBridge-49575038 | ChemBridge化合物-49575038 | Screening Compounds and Building Blocks |
{3-[[2-(2-fluorophenoxy)ethyl](2-methoxyethyl)amino]propyl}malonic acid (49575038) | |||
ChemBridge特有类药化合物/先导化合物-49575038,由AbMole(奥默生物)独家提供。具体售价货期请咨询AbMole(奥默生物)。运费额外计算。 | |||
M2542
![]() |
CTEP | CTEP | GluR |
mGluR5 inhibitor | |||
CTEP (RO4956371)是一种新型,长效的,口服生物有效的,mGlu5受体变构拮抗剂,IC50为2.2 nM,比作用于其他mGlu受体选择性高1000倍以上。 | |||
M11520
![]() |
Acridine Orange 10-Nonyl Bromide | 10-壬基溴代吖啶橙;吖啶橙10-溴壬烷 | Fluorescent Dye |
Nonylacridine orange | |||
Acridine Orange 10-Nonyl Bromide (吖啶橙10-溴壬烷)是一种与线粒体中的心磷脂结合的荧光探针,最大激发/发射波长为495 nm/521nm,发橙色荧光,用于观察线粒体,需室温避光储存。 | |||
M24642
![]() |
Landogrozumab | Landogrozumab | Others |
LY2495655; Anti-GDF8Myostatin Reference Antibody | |||
Landogrozumab (LY2495655) 是一种人源化抗肌肉生长抑制素单克隆抗体。Landogrozumab 可有效改善肌肉体积、握力和功能。Landogrozumab 可用于肌肉萎缩疾病的相关研究。 | |||
M25053 | Isecarosmab | Isecarosmab | Others |
M-6495 | |||
Isecarosmab (M-6495) 是一种抗 ADAMTS 单克隆抗体 (mAb),KD 值为 3.65 pM。Isecarosmab 具有软骨保护和抗炎活性。Isecarosmab 可以结合白蛋白以延长其血浆半衰期。 | |||
M28062 | PF-4950834 | PF-4950834 | ROCK |
PF-4950834 是一种有效的、选择性的、具有口服活性的、ATP竞争性的 rho kinase 抑制剂,对 ROCK2 和 ROCK1 的 IC50 分别为 8.35 nM 和 33.12 nM。PF-4950834 抑制中性粒细胞迁移。 |